GPGilles Pialoux

Gilles Pialoux

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gilles Pialoux has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • P.418 Prevalence of hepatitis C virus (HCV) and hepatitis B virus (HBV) infection among HIV infected persons (France, 2004)

    by C. Larsen, D. Salmon, G. Pialoux, D. Antona, L. Piroth, S. Pol, Y. Le Strat, E. Rosenthal, D. Neau, E. Delarocque-Astagneau, et al.


    • 1 October 2001
      • Vol. 25  (10) , 875-7

    [Coinfection HIV-HBV and the liver].

    by L Piroth, D Wendum, G Pialoux

  • Lipopeptides induce cell-mediated anti-HIV immune responses in seronegative volunteers

    by Gilles Pialoux, Hanne Gahéry-Ségard, Sandrine Sermet, Hubert Poncelet, Sandra Fournier, Laurence Gérard, André Tartar, Hélène Gras-Masse, Jean Paul Levy, Jean Gérard Guillet

    Test the efficacy of a mixture of six NEF (N1, N2, N3), GAG (G1, G2) and ENV (E) lipopeptides in the induction of B- and T-cell anti-HIV responses. A randomized phase I open-label dose-finding trial. Twenty-eight healthy seronegative volunteers received the lipopeptides, with or without the adjuvant QS21. Anti-HIV-peptide antibodies were detected by enzyme-linked immunosorbent assay and Western blotting. Induction of cellulary responses was assessed by proliferative test and 51Cr-release assay. Local and systemic adverse reactions were always mild or moderate. After three injections an antibody response was detected in 25 out of 28 volunteers (89%). T cells from 19 (79%) of the 24 volunteers proliferated in response to at least one peptide. The majority of the volunteers had induced a multispecific proliferative response; that is, cells from volunteers proliferated to two (five of 19), three (five of 19), four (three of 19) or five peptides (one of 19). Cytotoxic responses by anti-HIV CD8+ lymphocytes could be tested in 24 volunteers, 13 (54%) of whom had clear and reproducible responses, with strong activity in the remaining 12 (> 20% of specific lysis), and polyepitopic responses were detected in at least seven of the 13 responders. Cytotoxic responses were found against the whole NEF protein (clade B LAI) in three of four tested volunteers and cross-reactions with the proteins of clade B (MN) and clade A (Bangui) HIV-1 strains, and also HIV-2 ROD, were detected in one of two tested volunteers. Lipopeptides are promising immunogens for an AIDS vaccine.


    • 1 January 2001
      • Vol. 25  (1) , 93-6

    [HIV and the liver].

    by J F Cadranel, D Wendum, G Pialoux

    • 1 January 1996
      • Vol. 20  (3) , 307-11

    [Primary non-Hodgkin's lymphomas of the liver in human immunodeficiency virus infected patients. Three cases].

    by O Brugière, G Pialoux, F Carnot, S Pol, S Fournier, P Deslandes, P Trotot, B Dupont

    The occurrence of primary non Hodgkin's lymphoma of the liver has rarely been reported in patients with the human immunodeficiency virus infection. We report 3 cases in these patients, presenting with a single liver tumor in 2 cases and multiple tumors in one case. Diagnosis was made by guided-biopsy. Histologically, there was B diffuse large cell lymphoma in 2 cases, and immunoblastic lymphoma in one case. In one case, RNA of Epstein-Barr virus was found in the nucleus of tumor cells by in situ hybridization. No extrahepatic localization was found in any of the 3 cases. One patient died one week after diagnosis, but the 2 other patients were treated by chemotherapy and were still alive 6 and 30 months later. In patients infected by human immunodeficiency virus, primary non Hodgkin's lymphoma should be investigated in case of liver tumor in order to provide early treatment.

    • 7 March 1992
      • Vol. 21  (9) , 417-21

    [Lung abscess caused by Rhodococcus (Corynebacterium) equi in HIV infection. Two cases].

    by G Pialoux, S Fournier, B Dupont, J Fleury, P Sansonetti, F Goldstein, P Trotot

    Rhodococcus (Corynebacterium) equi is a well-known Gram positive bacillus which is usually pathogenic in farm animals but rarely causes diseases in humans. Only 30 cases of human infection have been reported in the literature. R. equi has recently been added to the list of opportunistic agents in severe HIV infection. Its most common manifestation in immunocompromised is a slowly progressive pneumonia which may cavitate. R. equi pulmonary infections are difficult to treat: they usually require prolonged parenteral antibiotic therapy and often need surgical treatment. Two cases of cavitary pneumonia in patients with severe HIV infection are reported here. In one case the disease was associated with pulmonary Kaposi sarcoma and pneumocystis pneumonia; the other case was the first opportunistic infection in the course of HIV infection.